A Systematic Review of Discrete-Choice Experiments and Conjoint Analysis Studies in People with Multiple Sclerosis
- PMID: 29313265
- DOI: 10.1007/s40271-017-0296-y
A Systematic Review of Discrete-Choice Experiments and Conjoint Analysis Studies in People with Multiple Sclerosis
Abstract
Background: Multiple sclerosis (MS) is a chronic disabling, inflammatory, and degenerative disease of the central nervous system that, in most cases, requires long-term disease-modifying treatment (DMT). The drugs used vary in efficacy and adverse effect profiles. Several studies have used attribute-based stated-preference methods, primarily to investigate patient preferences for initiating or escalating DMT.
Objectives: To conduct a systematic review of attribute-based stated-preference studies in people with MS to identify common methods employed and to assess study quality, with reference to the specific challenges of this disease area.
Methods: We conducted a systematic search for studies related to attribute-based stated-preference and MS in multiple databases, including Cochrane and MEDLINE. Studies were included if they were published in a peer-reviewed journal, were on the topic of MS, and used a survey methodology that measured stated preferences for attributes of a whole. Analysis was conducted using narrative synthesis and summary statistics. Study quality was judged against the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) conjoint analysis checklist.
Results: We identified 16 relevant articles reporting 17 separate studies, all but one focusing on DMTs. Most studies were discrete-choice experiments. Study quality was generally high, but we recommend the following: (1) that consideration of sample sizes be improved, (2) that survey design choices be justified and documented, (3) that qualitative approaches for attribute and level selection be incorporated to better involve patients, and (4) that reporting of experimental practice be improved. The effects of DMTs on reproduction and the impact of how risk and uncertainty are presented were identified as neglected research topics. The ISPOR conjoint analysis checklist was found to be unsuitable for the assessment of study quality.
Conclusion: Attribute-based stated preference is a useful method with which to examine the preferences of people with MS in their choice of DMT. However, further research embracing the methodological recommendations identified, particularly greater use of qualitative methods in attribute development, is needed.
Similar articles
-
A discrete choice experiment to determine UK patient preference for attributes of disease modifying treatments in Multiple Sclerosis.J Med Econ. 2017 Aug;20(8):863-870. doi: 10.1080/13696998.2017.1336099. Epub 2017 Jun 14. J Med Econ. 2017. PMID: 28562125
-
A Systematic Review of Discrete Choice Experiments and Conjoint Analysis on Genetic Testing.Patient. 2022 Jan;15(1):39-54. doi: 10.1007/s40271-021-00531-1. Epub 2021 Jun 4. Patient. 2022. PMID: 34085205
-
Decision Making About Disease-Modifying Treatments for Relapsing-Remitting Multiple Sclerosis: Stated Preferences and Real-World Choices.Patient. 2023 Sep;16(5):457-471. doi: 10.1007/s40271-023-00622-1. Epub 2023 Apr 18. Patient. 2023. PMID: 37072663
-
Eliciting Preferences in Dentistry with Multiattribute Stated Preference Methods: A Systematic Review.JDR Clin Trans Res. 2018 Oct;3(4):326-335. doi: 10.1177/2380084418780324. Epub 2018 Jun 1. JDR Clin Trans Res. 2018. PMID: 30931788
-
Factors Associated with Patient Preferences for Disease-Modifying Therapies in Multiple Sclerosis.J Manag Care Spec Pharm. 2017 Aug;23(8):822-830. doi: 10.18553/jmcp.2017.23.8.822. J Manag Care Spec Pharm. 2017. PMID: 28737987 Free PMC article.
Cited by
-
Innovative Medical Technology and the Treatment Decision-Making Process in Multiple Sclerosis: A Focus Group Study to Examine Patient Perspectives.Patient Prefer Adherence. 2021 May 7;15:927-937. doi: 10.2147/PPA.S306132. eCollection 2021. Patient Prefer Adherence. 2021. PMID: 33994779 Free PMC article.
-
Patients' Preferences for Sphingosine-1-Phosphate Receptor Modulators in Multiple Sclerosis Based on Clinical Management Considerations: A Choice Experiment.Patient. 2024 Nov;17(6):685-696. doi: 10.1007/s40271-024-00699-2. Epub 2024 May 15. Patient. 2024. PMID: 38748388
-
Decisional Conflict Regarding Disease-Modifying Treatment Choices Among Patients with Mid-Stage Relapsing-Remitting Multiple Sclerosis.Patient Prefer Adherence. 2024 Jun 7;18:1163-1171. doi: 10.2147/PPA.S459242. eCollection 2024. Patient Prefer Adherence. 2024. PMID: 38863945 Free PMC article.
-
Patient Preference Studies for Advanced Prostate Cancer Treatment Along the Medical Product Life Cycle: Systematic Literature Review.Patient Prefer Adherence. 2022 Jun 28;16:1539-1557. doi: 10.2147/PPA.S362802. eCollection 2022. Patient Prefer Adherence. 2022. PMID: 35789822 Free PMC article. Review.
-
Assessing Pharmacists' Preferences towards Efficacy Attributes of Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis.Pharmacy (Basel). 2020 Apr 7;8(2):61. doi: 10.3390/pharmacy8020061. Pharmacy (Basel). 2020. PMID: 32272683 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical